The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Open accessAbstract
A growing number of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors. These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports. We used the beta-arrestin PathHunter assay system, a newly developed, generic GPCR assay format that measures beta-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing. This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation. We screened a large number of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of approximately 400 lipid molecules to try to identify the receptor ligand in an unbiased fashion. GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate. The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids. G2A receptor was confirmed to be an oxidized free fatty acid receptor. In addition, we discovered that 3,3'-diindolylmethane, a dietary molecule from cruciferous vegetables, which has known anti-cancer properties, to be a CB(2) receptor partial agonist, with binding affinity around 1 microm. The anti-inflammatory effect of 3,3'-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB(2).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001) · Science · doi:10.1126/science.1061781 · Cited by 332
RetractedBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1188 · Cited by 703
Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C., & Bradfield, C. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9543 · Cited by 588
Noguchi, K., Ishii, S., & Shimizu, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302648200 · Cited by 557
The cannabinoid system and immune modulation
Klein, T. W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., & Friedman, H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 524
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A., Frossard, J.-L., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 472
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5
Lee, C.-W., Rivera, R., Gardell, S., Dubin, A. E., & Chun, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603670200 · Cited by 471
Identification of GPR55 as a lysophosphatidylinositol receptor
Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.078 · Cited by 459
Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives
Aggarwal, B. B., & Ichikawa, H. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1993 · Cited by 434
Medium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84
Wang, J., Wu, X., Simonavicius, N., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608019200 · Cited by 417
G protein–coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth
Pasternack, S. M., von Kügelgen, I., Aboud, K. A., Lee, Y.-A., Rüschendorf, F., Voss, K., Hillmer, A. M., Molderings, G. J., Franz, T., Ramirez, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.84 · Cited by 411
In silico patent searching reveals a new cannabinoid receptor
Baker, D., Pryce, G., Davies, W. L., & Hiley, C. R. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 348
Cannabinoid CB2 receptors in human brain inflammation
Benito, C., Tolón, R. M., Pazos, M. R., Núñez, E., Castillo, A. I., & Romero, J. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707505 · Cited by 291
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
McKallip, R. J., Lombard, C., Fisher, M., Martin, B. R., Ryu, S., Grant, S., Nagarkatti, P. S., & Nagarkatti, M. (2002) · Blood · doi:10.1182/blood-2002-01-0098 · Cited by 288
Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane
Chen, I. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1631 · Cited by 285
Staton, P. C., Hatcher, J. P., Walker, D. J., Morrison, A. D., Shapland, E. M., Hughes, J. P., Chong, E., Mander, P. K., Green, P. J., Billinton, A., et al. (2008) · Pain · doi:10.1016/j.pain.2008.04.006 · Cited by 270
Wright, K. L., Duncan, M., & Sharkey, K. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 264
Kohno, M., Hasegawa, H., Inoue, A., Muraoka, M., Miyazaki, T., Oka, K., & Yasukawa, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.175 · Cited by 263
Migration to Apoptotic “Find-me” Signals Is Mediated via the Phagocyte Receptor G2A
Peter, C., Waibel, M., Radu, C. G., Yang, L. V., Witte, O. N., Schulze-Osthoff, K., Wesselborg, S., & Lauber, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706586200 · Cited by 258
G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine
Murakami, N., Yokomizo, T., Okuno, T., & Shimizu, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406561200 · Cited by 252
Johns, D. G., Behm, D. J., Walker, D. J., Ao, Z., Shapland, E. M., Daniels, D. A., Riddick, M., Dowell, S., Staton, P. C., Green, P., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707419 · Cited by 242
Kotarsky, K., Boketoft, Å., Bristulf, J., Nilsson, N. E., Norberg, Å., Hansson, S., Owman, C., Sillard, R., Leeb-Lundberg, L. M. F., & Olde, B. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098848 · Cited by 237
The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor
Tabata, K.-I., Baba, K., Shiraishi, A., Ito, M., & Fujita, N. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.063 · Cited by 224
Chen, I., Safe, S., & Bjeldanes, L. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00060-3 · Cited by 222
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Uhlenbrock, K., Gassenhuber, H., & Kostenis, E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00041-4 · Cited by 213
Radu, C. G., Nijagal, A., McLaughlin, J., Wang, L., & Witte, O. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409415102 · Cited by 211
T cell chemotaxis to lysophosphatidylcholine through the G2A receptor
Radu, C. G., Yang, L. V., Riedinger, M., Au, M., & Witte, O. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536801100 · Cited by 210
Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation
Jellinck, P. H., Gekforkert, P., Riddick, D. S., Okey, A. B., Michnovicz, J. J., & Bradlow, H. L. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90258-x · Cited by 190
Obinata, H., Hattori, T., Nakane, S., Tatei, K., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507787200 · Cited by 183
Plant-derived 3,3′-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells
Le, H. T., Schaldach, C. M., Firestone, G. L., & Bjeldanes, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300588200 · Cited by 182
Lee, C.-W., Rivera, R., Dubin, A. E., & Chun, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610826200 · Cited by 177
Identification of a lysophosphatidylserine receptor on mast cells
Sugo, T., Tachimoto, H., Chikatsu, T., Murakami, Y., Kikukawa, Y., Sato, S., Kikuchi, K., Nagi, T., Harada, M., Ogi, K., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.069 · Cited by 159
A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M.
Weng, Z., Fluckiger, A., Nisitani, S., Wahl, M., Le, L., Hunter, C., Fernal, A. A., Beau, M. L., & Witte, O. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.21.12334 · Cited by 158
Gong, Y., Sohn, H., Xue, L., Firestone, G. L., & Bjeldanes, L. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4162 · Cited by 151
Endocannabinoids and the Regulation of Bone Metabolism
Bab, I., Ofek, O., Tam, J., Rehnelt, J., & Zimmer, A. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01675.x · Cited by 142
Identification of Farnesyl Pyrophosphate and N-Arachidonylglycine as Endogenous Ligands for GPR92
Oh, D. Y., Yoon, J. M., Moon, M. J., Hwang, J., Choe, H., Lee, J. Y., Kim, J. I., Kim, S., Rhim, H., O’Dell, D. K., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708908200 · Cited by 142
Lin, P., & Ye, R. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209101200 · Cited by 132
Cho, H., Seon, M. R., Lee, Y. M., Kim, J., Kim, J.-K., Kim, S. G., & Park, J. H. Y. (2008) · Journal of Nutrition · doi:10.1093/jn/138.1.17 · Cited by 130
CB2 receptors as new therapeutic targets for liver diseases
Lotersztajn, S., Teixeira-Clerc, F., Julien, B., Deveaux, V., Ichigotani, Y., Manin, S., Nhieu, J. T. V., Karsak, M., Zimmer, A., & Mallat, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707511 · Cited by 114
Hirose, M., Egashira, S., Goto, Y., Hashihayata, T., Ohtake, N., Iwaasa, H., Hata, M., Fukami, T., Kanatani, A., & Yamada, K. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.038 · Cited by 112
Yamamoto, W., Mikami, T., & Iwamura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.010 · Cited by 89
Dyson, A., Peacock, M., Chen, A., Courade, J.-P., Yaqoob, M., Groarke, A., Brain, C., Loong, Y., & Fox, A. (2005) · Pain · doi:10.1016/j.pain.2005.03.037 · Cited by 85
Arévalo‐Martín, Á., García‐Ovejero, D., Gómez, O., Rubio‐Araiz, A., Navarro‐Galve, B., Guaza, C., Molina‐Holgado, E., & Molina‐Holgado, F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707466 · Cited by 83
The endocannabinoid system in cancer—Potential therapeutic target?
Flygare, J., & Sander, B. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.12.008 · Cited by 77
Xue, L., Firestone, G. L., & Bjeldanes, L. F. (2005) · Oncogene · doi:10.1038/sj.onc.1208434 · Cited by 76
Niedernberg, A., Tunaru, S., Blaukat, A., Ardati, A., & Kostenis, E. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00119-5 · Cited by 72
Ignatov, A., Lintzel, J., Kreienkamp, H., & Schaller, H. C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.006 · Cited by 70
Paugh, S. W., Cassidy, M. P., He, H., Milstien, S., Sim‐Selley, L. J., Spiegel, S., & Selley, D. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020552 · Cited by 68
Cell‐based assays in GPCR drug discovery
Siehler, S. (2008) · Biotechnology Journal · doi:10.1002/biot.200800001 · Cited by 66
Yan, Y.-X., Boldt‐Houle, D. M., Tillotson, B. P., Gee, M. A., D'Eon, B. J., Chang, X.-J., Olesen, C. E. M., & Palmer, M. A. J. (2002) · SLAS DISCOVERY · doi:10.1177/108705702237677 · Cited by 59
Maccarrone, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707444 · Cited by 54
3,3′-Diindolylmethane stimulates murine immune function in vitro and in vivo
Xue, L., Pestka, J. J., Li, M., Firestone, G. L., & Bjeldanes, L. F. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.05.004 · Cited by 49
Cited by
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
LPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Molecular Targets of the Phytocannabinoids: A Complex Picture
Morales, P., Hurst, D. P., & Reggio, P. H. (2017) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-319-45541-9_4 · Cited by 454
Metadata
- Authors
- Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 284
- Issue
- 18
- Pages
- 12328-12338
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2072840386
- Cited by
- 311
- References
- 58
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.